Regulation of Biological/Drug Development: An Introduction

Examine preclinical and clinical testing, sources of Good Clinical Practice (GCP) requirements and phases of the clinical trial process. Assess the obligations of sponsors and investigators. Discuss how to interact with FDA. Review compliance and enforcement considerations.

Natasha V. Leskovsek, Of Counsel, Cooley LLP

This session was recorded as part of FDLI’s Virtual Introduction to Biologics and Biosimilars Laws and Regulations Course in October 2021. 


Get Access

  • +$100 for nonmembers

Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.

Virtual Learning FAQ

On-demand webinar content is sent via email as soon as we are able to process and verify your order. This usually occurs within 1 business day.


On-demand content can be played back on most devices.


CLE credit is not currently available for pre-recorded sessions.

Related Content